Financial Results for the half year and financial year ended March 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Adeshwar Meditex Ltd's board, at a meeting on May 28, 2025, approved the audited financial results for the half year and full year ended March 31, 2025. The statutory auditors, J N Gupta & Co. LLP, issued an unmodified (clean) opinion on the results. The company manufactures and trades sterile wound dressings, gauze, cotton products, medical bandages, and first-aid kits, and is listed on the SME exchange, so it is exempt from IND-AS adoption. No investor complaints were pending or received during the period. Detailed related party transactions were also disclosed, including salaries, loans from directors (with interest), and business dealings with two related entities: Moksha Biosurgicals Pvt Ltd (purchases of ₹3.31 lakhs and rent of ₹10.80 lakhs) and Shivadesh Meditex (purchases of ₹13.58 lakhs and sales of ₹45.56 lakhs). The actual financial figures from Annexure-I were not included in the document text provided.
A clean audit opinion is positive for credibility and signals no material concerns raised by auditors. However, the absence of detailed financial figures (revenue, profit, margins) in this filing limits direct assessment of business performance. Shareholders should refer to the attached Annexure-I for actual numbers.